Tag: protein

Revolutionizing Dairy: Quest, Nurri, and Pioneer Pastures Strategies

In an industry entrenched in tradition, a radical innovation is taking root, rewriting the conventions of what milk can be. Ultra-filtered milk, a product of advanced filtration and formulation techniques, is reshaping the dairy industry with a bold promise of higher protein, lower sugar, and functional benefits without compromising on the authentic taste and nutrition […]

Revolutionizing Protein Sequencing with DARPA’s PROSE Program

In the vast cosmos of biotechnology, the shining star of public-private innovation efforts is DARPA’s PROSE program. This innovative initiative is not just a beacon in the darkness; it’s a veritable lighthouse, guiding the way towards improved national defense, public health security, and economic competitiveness. Through the development of advanced tools to detect unknown and […]

The Impact of AI on Protein Folding Startups

In the dynamic world of scientific innovation, Meta’s recent ‘Superintelligence’ initiative, spearheaded by the prodigious Alexandr Wang, is a testament to the shifting paradigms in research and development. This ambitious project is a harbinger of the increasingly symbiotic relationship between technology and science, a trend that has been gaining momentum across the globe and is […]

Enhancing Protein Elution with Hydrophobic Interaction Chromatography

In a striking advancement for protein purification technologies, scientists at Forschungszentrum Jülich have reimagined the underlying assumptions of hydrophobic interaction chromatography (HIC) isotherms, a cornerstone in the world of biopharmaceutical research. The results are a testament to the transformative potential of interrogating and recalibrating accepted scientific norms. HIC is a workhorse in the bioprocessing industry, […]

Arkeon Startup Files for Insolvency: Gas Fermentation Lessons

The recent insolvency of Arkeon, the ambitious gas fermentation startup, is a stark reminder of the volatility in the biotech sector. Arkeon, well-known for its audacious mission of creating ‘protein from air,’ may have foundered, but its journey has underscored both the high-risk and high-reward nature of biotech innovation. Arkeon’s approach was founded on gas […]

Amplifye Enzyme Enhances Protein Digestion for Health Benefits

In a remarkable leap forward for biotechnology and nutritional science, Amplifye, a spinoff from UC Davis led by former Amyris CEO John Melo, has unveiled its pioneering enzyme designed to turbocharge protein digestion. The enzyme, known as P24, is set to revolutionize dietary practices and nutritional outcomes by enhancing the body’s absorption of nutrients and […]

Advancing Protein Splicing Medicines with $135M Series B Funding

In the high-stakes world of gene therapy, Barcelona-based SpliceBio has carved a unique path by focusing on delivering replacement proteins for mutated genes. This innovative approach is a refreshing departure from traditional gene splicing or editing techniques, and it’s making waves in the biotech community. At the heart of their groundbreaking work is SB-007, a […]

Analyzing Intellia Therapeutics’ Potential with Financial Insights

In the rapidly progressing world of bioengineering, Intellia Therapeutics stands as a beacon of innovation, leading the charge in harnessing the transformative potential of the Crispr/Cas9 gene-editing technology. This avant-garde biotechnological tool, scientifically termed as Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), is rewriting the rules of genetic engineering by enabling precise […]

Avidity’s Del-Brax FDA Accelerated Filing for FSHD Treatment

In a remarkable stride for the biotech industry, San Diego-based Avidity Biosciences has secured an agreement with the U.S. Food and Drug Administration (FDA) for expedited filing of their revolutionary drug, Del-Brax. This breakthrough therapy is designed to combat facioscapulohumeral muscular dystrophy (FSHD)—a rare genetic condition characterized by a progressive weakening of the muscles. This […]

Hope for Rare Cancer Patient: TCR-T Cell Therapy Trial

In a groundbreaking clinical trial, a patient with a rare form of cancer is finding hope through TCR-T Cell Therapy. This innovative immunotherapy approach, conducted through a collaboration between Memorial Cancer Institute and Moffett Cancer Center, involves modifying the patient’s T-cells to target specific proteins in cancer cells. By harnessing the power of the body’s […]